Original Source(s)
Related Content
HHS Seeks Broader Access to Health Data
"We can’t do anything our agreements don’t allow us to do"
June 4, 2026
-
12 min
FDA Approves New First-Line TNBC Regimen
Phase 3 results showed longer progression-free survival with pembrolizumab plus sacituzumab govitecan-hziy than with pembrolizumab plus chemotherapy in previously untreated PD-L1-positive advanced triple-negative breast cancer.
June 26, 2026
-
3 min
Medical Oddities: The Economics of Shut-Eye
Sleep became a commodity, tea became a therapy, and cats got a reprieve this week.
by Teraya Smith
June 11, 2026
-
6 min
